PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Autoimmunity

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jaut.2011.02.006PMID 21396797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple sclerosis: risk factors, prodromes, and potential causal pathways

  2010cited by this paper
• The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses.

  2010cited by this paper
• Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response1

  2009cited by this paper
• p110γ and p110δ isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease

  2009cited by this paper
• Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.

  2009cited by this paper
• Antagonism of the Chemokine Receptors CXCR3 and CXCR4 Reduces the Pathology of Experimental Autoimmune Encephalomyelitis

  2008cited by this paper
• Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease.

  2008cited by this paper
• Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production.

  2008cited by this paper
• Isoform-Specific Functions of Phosphoinositide 3-Kinases: p110δ but Not p110γ Promotes Optimal Allergic Responses In Vivo1

  2008cited by this paper
• The p110δ of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation

  2008cited by this paper
• Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo.

  2008cited by this paper
• Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis1

  2008cited by this paper
• Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells

  2008cited by this paper
• The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion.

  2007cited by this paper
• p110gamma and p110delta phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells.

  2007cited by this paper
• p110γ and p110δ Phosphoinositide 3-Kinase Signaling Pathways Synergize to Control Development and Functions of Murine NK Cells

  2007cited by this paper
• Leukocyte PI3Kgamma and PI3Kdelta have temporally distinct roles for leukocyte recruitment in vivo.

  2007cited by this paper
• Multiple sclerosis: the environment and causation

  2007cited by this paper
• IL-17 family cytokines and the expanding diversity of effector T cell lineages.

  2007cited by this paper
• The p110δ Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells1

  2006cited by this paper
• Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival.

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Transforming growth factor-beta induces development of the T(H)17 lineage.

  2006cited by this paper
• Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells.

  2006cited by this paper
• Expanding the effector CD4 T-cell repertoire: the Th17 lineage.

  2006cited by this paper
• Cutting Edge: The Phosphoinositide 3-Kinase p110δ Is Critical for the Function of CD4+CD25+Foxp3+ Regulatory T Cells1

  2006cited by this paper
• Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model

  2006cited by this paper
• Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils.

  2005cited by this paper
• Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

  2005cited by this paper
• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

  2005cited by this paper
• Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.

  2005cited by this paper
• Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice.

  2004cited by this paper
• Essential role for the p110δ phosphoinositide 3-kinase in the allergic response

  2004cited by this paper
• Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue.

  2004cited by this paper
• Essential role for the p110delta phosphoinositide 3-kinase in the allergic response.

  2004cited by this paper
• Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands

  2004cited by this paper
• Defective dendritic cell migration and activation of adaptive immunity in PI3Kγ‐deficient mice

  2004cited by this paper
• Inhibition of Generation of Cytotoxic T Lymphocyte Activity by a CCL19/Macrophage Inflammatory Protein (MIP)-3β Antagonist*

  2004cited by this paper
• Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing.

  2004cited by this paper
• Cutting Edge: Differential Roles for Phosphoinositide 3-Kinases, p110γ and p110δ, in Lymphocyte Chemotaxis and Homing1

  2004cited by this paper
• Selective role of PI3Kδ in neutrophil inflammatory responses

  2003cited by this paper
• A Role for Macrophage Inflammatory Protein-3α/CC Chemokine Ligand 20 in Immune Priming During T Cell-Mediated Inflammation of the Central Nervous System1

  2003cited by this paper
• Selective role of PI3K delta in neutrophil inflammatory responses.

  2003cited by this paper
• Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement

  2003cited by this paper
• Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

  2003cited by this paper
• Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice

  2002cited by this paper
• Essential, Nonredundant Role for the Phosphoinositide 3-Kinase p110δ in Signaling by the B-Cell Receptor Complex

  2002cited by this paper
• Up-Regulation of CCR5 and CCR6 on Distinct Subpopulations of Antigen-Activated CD4+ T Lymphocytes1

  2002cited by this paper
• A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation

  2002cited by this paper
• Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase

  2002cited by this paper
• Synthesis and function of 3-phosphorylated inositol lipids.

  2001cited by this paper
• Coregulation of CXC Chemokine Receptor and CD4 Expression on T Lymphocytes During Allogeneic Activation1

  2001cited by this paper
• Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

  2000cited by this paper
• Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110α Subunit of Phosphoinositide 3-Kinase*

  1999cited by this paper
• P110delta, a novel phosphoinositide 3-kinase in leukocytes.

  1997cited by this paper
• p110δ, a novel phosphoinositide 3-kinase in leukocytes

  1997cited by this paper
• Determination of lymphocyte division by flow cytometry.

  1994cited by this paper
• EncephalomyelitisDevelopment of Experimental Autoimmune IL-17 Plays an Important Role in the

  year unknowncited by this paper

• Multi‐omics integration analysis identifies INPP4B as a T‐cell‐specific activation suppressor

  2025cites this paper
• T Cell-Specific Inactivation of the PI3K p110α Catalytic Subunit: Effect in T Cell Differentiation and Antigen-Specific Responses

  2025cites this paper
• PI3Kδ Bridges Microbial Surveillance with Antigen Presentation to Reinforce Intestinal Immunity

  2025cites this paper
• Inhibition of phosphoinositide 3-kinase activity attenuates neutrophilic airway inflammation and inhibits pyrin domain-containing 3 inflammasome activation in an ovalbumin-lipopolysaccharide-induced asthma murine model

  2024cites this paper
• Discovery of Novel Azaindoles as Potent and Selective PI3Kδ Inhibitors for Treatment of Multiple Sclerosis.

  2024cites this paper
• Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II—Benzimidazole Derivatives

  2022cites this paper
• Control of CD4+ T Cell Differentiation and Function by PI3K Isoforms.

  2022cites this paper
• Phosphatidylinositol 3‐Kinase δ Deficiency Protects From Antimyeloperoxidase Vasculitis

  2022cites this paper
• Immune cells transcriptome-based drug repositioning for multiple sclerosis

  2022influential citation
• The Role of PI3K Isoforms in Autoimmune Disease.

  2022cites this paper
• The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis

  2021cites this paper
• PI3K in T Cell Adhesion and Trafficking

  2021cites this paper
• PI3-Kinase p110α Deficiency Modulates T Cell Homeostasis and Function and Attenuates Experimental Allergic Encephalitis in Mature Mice

  2021cites this paper
• Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.

  2021cites this paper
• Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation

  2020cites this paper
• Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy

  2020cites this paper
• Identification and functional analysis of specific MS risk miRNAs and their target genes.

  2020cites this paper
• Parsaclisib Is a Next-Generation PI3Kδ Inhibitor With Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy a

  2020cites this paper
• Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.

  2020cites this paper
• PI3K Orchestrates T Follicular Helper Cell Differentiation in a Context Dependent Manner: Implications for Autoimmunity

  2019cites this paper
• Cellular mechanisms underlying steroid-resistant asthma

  2019cites this paper
• PI3K activity in dendritic cells exerts paradoxical effects during autoimmune inflammation.

  2019cites this paper
• Phosphoinositide 3-Kinase P110δ-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation

  2019cites this paper
• Targeting PI3Kδ function for amelioration of murine chronic graft‐versus‐host disease

  2019cites this paper
• Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions.

  2019cites this paper
• The PI3K/AKT signaling pathway in regulatory T‐cell development, stability, and function

  2018cites this paper
• MicroRNA‐21 drives severe, steroid‐insensitive experimental asthma by amplifying phosphoinositide 3‐kinase–mediated suppression of histone deacetylase 2

  2017cites this paper
• Rapamycin alleviates inflammation and muscle weakness, while altering the Treg/Th17 balance in a rat model of myasthenia gravis

  2017cites this paper
• First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases

  2017cites this paper
• Deficiency of PI3-Kinase catalytic isoforms p110γ and p110δ in mice enhances the IL-17/G-CSF axis and induces neutrophilia

  2017cites this paper
• Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ

  2017cites this paper
• Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.

  2017cites this paper
• MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease

  2017cites this paper
• Th17/Treg immunoregulation and implications in treatment of sulfur mustard gas-induced lung diseases

  2017cites this paper
• Group 2 ILCs: A way of enhancing immune protection against human helminths?

  2017cites this paper
• Characterization of long non-coding RNA-mediated competing endogenous RNA network to reveal potential long non-coding RNA biomarkers in rheumatoid arthritis patients under anti-TNF treatment

  2017cites this paper
• ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.

  2016cites this paper
• Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.

  2016cites this paper
• Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections

  2016cites this paper
• PI3Kδ and primary immunodeficiencies

  2016cites this paper
• Autoimmunity in primary T-cell immunodeficiencies

  2016cites this paper
• Investigation of the mechanisms of respiratory infection-induced lung disease

  2015influential citation
• PI3K inhibitors in inflammation, autoimmunity and cancer

  2015cites this paper
• The physical influence of inositides—a disproportionate effect?

  2015cites this paper
• Activation of TGF‐β‐induced non‐Smad signaling pathways during Th17 differentiation

  2015cites this paper
• PI3K signalling in inflammation.

  2015cites this paper
• PI3K signaling in arterial diseases: Non redundant functions of the PI3K isoforms.

  2015cites this paper
• Composés hétérocycliques destinés à être utilisés dans le traitement de troubles médiés par pi3k-gamma

  2015cites this paper
• Pharmacological targeting of neutrophilic airway inflammation in COPD

  2015cites this paper
• Inhibition of PI3Kδ Improves Systemic Lupus in Mice

  2014cites this paper
• Phosphoinositide-3 kinase/protein kinase-B/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target?

  2014cites this paper
• ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis

  2014cites this paper
• PI3K inhibitors as potential therapeutics for autoimmune disease.

  2014cites this paper
• IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.

  2014cites this paper
• Inhibition of PI3Kδ Reduces Kidney Infiltration by Macrophages and Ameliorates Systemic Lupus in the Mouse

  2014cites this paper
• This information is current as Systemic Lupus in the Mouse AmelioratesInfiltration by Macrophages and Reduces Kidney δ Inhibition of PI 3 K and

  2014cites this paper
• Systemic Lupus in the Mouse Ameliorates Infiltration by Macrophages and Reduces Kidney δ Inhibition of PI3K

  2014cites this paper
• Macrophage phosphoinositide 3-kinase p110delta regulates intestinal homeostasis by directing adaptive immunity and enhancing microbial clearance

  2013influential citation
• Pathway-based analysis of primary biliary cirrhosis genome-wide association studies

  2013cites this paper
• Signaling by the phosphoinositide 3-kinase family in immune cells.

  2013cites this paper
• B-Cell Receptor Signaling Inhibitors for Treatment of Autoimmune Inflammatory Diseases and B-Cell Malignancies

  2013cites this paper
• The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.

  2013cites this paper
• Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice

  2013cites this paper
• Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.

  2013cites this paper
• Autoimmunity in 2012

  2013cites this paper
• Identification of Potential Cytokine Pathways for Therapeutic Intervention in Murine Primary Biliary Cirrhosis

  2013cites this paper
• Distinct Chemokine Receptor Axes Regulate Th9 Cell Trafficking to Allergic and Autoimmune Inflammatory Sites

  2013cites this paper
• Dose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor

  2013cites this paper
• Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells

  2013cites this paper
• Autoimmune Inflammatory Sites Th 9 Cell Trafficking to Allergic and Distinct Chemokine Receptor Axes Regulate

  2013cites this paper
• PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models.

  2013cites this paper
• PI3Kγ Drives Priming and Survival of Autoreactive CD4+ T Cells during Experimental Autoimmune Encephalomyelitis

  2012influential citation
• The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases

  2012cites this paper
• Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies

  2012cites this paper
• All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells

  2012cites this paper
• Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.

  2012cites this paper
• A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiation.

  2012cites this paper
• Does the PI3K pathway promote or antagonize regulatory T cell development and function?

  2012cites this paper
• PI3Kδ Is Essential for Tumor Clearance Mediated by Cytotoxic T Lymphocytes

  2012cites this paper
• Autoimmunity in 2011

  2012cites this paper
• PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

  2012cites this paper
• The Long-Term Marriage Between Autoimmunity and Internal Medicine: A Homage to Manuel Carlos Dias

  2012cites this paper
• Targeting IL-17 and TH17 cells in chronic inflammation

  2012cites this paper
• Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies

  2012cites this paper
• Anti-Chlamydial Th17 Responses Are Controlled by the Inducible Costimulator Partially through Phosphoinositide 3-Kinase Signaling

  2012cites this paper
• The long-term marriage between autoimmunity and internal medicine. Festschrift dedicated to Dr. Manuel Carlos Dias.

  2012cites this paper